Ingredient

Trastuzumab

Trastuzumab is a monoclonal antibody that targets the HER2 protein.

See medicines used for Others & Special
All medicines
12
Single ingredient
10
Combination
2
Prescription medication
12

MFDS ingredient code M090706

What does it do?

Trastuzumab is a monoclonal antibody produced using recombinant DNA technology, primarily used for the treatment of cancer cells that overexpress the HER2 protein. This ingredient is classified as an antitumor agent that inhibits cancer progression by blocking growth signals in cancer cells.

Trastuzumab binds to the HER2 receptors on the surface of cancer cells, interfering with signal transduction. This action suppresses the proliferation and survival of cancer cells and helps immune cells to attack cancer cells.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Trastuzumab is distinguished from other anticancer agents by its specific binding to the HER2 protein. Additionally, as a monoclonal antibody, it is characterized by its approach of harnessing the immune system.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

12 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.